Sight Sciences director granted RSU award
Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Burbach Gerhard F reported acquisition or exercise transactions in this Form 4 filing.
Sight Sciences, Inc. reported that director Gerhard F. Burbach received a grant of 28,261 restricted stock units (RSUs) under the company’s Non-Employee Director Compensation Program. The award equals approximately $130,000 of common stock based on the closing price on June 4, 2026.
The RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual stockholder meeting, if he continues serving as a director through that date. Following this grant, he directly holds a total of 123,207 common shares and RSUs, including 44,922 shares of common stock and RSUs from current and prior awards.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 28,261 shares
Grant/Award
1 txn
Insider
Burbach Gerhard F
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 28,261 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 123,207 shares (Direct)
Footnotes (2)
- F1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
- F2. Includes (i) 44,922 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 49,844 RSUs granted to the Reporting Person on 5/12/2025 which are subject to vesting as previously reported.
Key Figures
RSUs granted: 28,261 RSUs
Grant value: approximately $130,000
Total holdings after grant: 123,207 shares/RSUs
+3 more
6 metrics
RSUs granted
28,261 RSUs
Non-Employee Director Compensation Program grant on June 4, 2026
Grant value
approximately $130,000
Value of RSUs based on closing price on June 4, 2026
Total holdings after grant
123,207 shares/RSUs
Direct holdings following the June 4, 2026 RSU award
Common stock held
44,922 shares
Outstanding common shares held directly by the director
Prior RSU award
49,844 RSUs
RSUs granted on May 12, 2025, still subject to vesting
Vesting date
earlier of June 4, 2027 or 2027 annual meeting
Condition for vesting of newly granted RSUs
Key Terms
restricted stock units ("RSUs"), Non-Employee Director Compensation Program, vest, contingent right, +1 more
5 terms
restricted stock units ("RSUs") financial
"Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Non-Employee Director Compensation Program financial
"made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program"
vest financial
"The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
contingent right financial
"Each RSU represents a contingent right to receive one share of the Issuer's common stock"
annual meeting of stockholders financial
"the date of the Issuer's 2027 annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sight Sciences (SGHT) disclose about director Gerhard Burbach’s new award?
Sight Sciences disclosed that director Gerhard F. Burbach received 28,261 restricted stock units as part of its Non-Employee Director Compensation Program. These RSUs were valued at approximately $130,000 based on the June 4, 2026 closing price of the company’s common stock.
How many RSUs did Sight Sciences grant to Gerhard Burbach and what is their value?
Sight Sciences granted Gerhard F. Burbach 28,261 restricted stock units, equal to about $130,000 of common stock. The value was determined using the company’s closing stock price on June 4, 2026, the date the grant was made under the director compensation program.
When do Gerhard Burbach’s new Sight Sciences RSUs vest?
The 28,261 RSUs granted to Gerhard F. Burbach vest on the earlier of June 4, 2027 or Sight Sciences’ 2027 annual meeting of stockholders. Vesting is conditioned on his continued service as a director on the company’s board through that vesting date.
Is Gerhard Burbach’s new RSU grant from Sight Sciences an open-market purchase?
No. The 28,261 RSUs are a compensation grant, not an open-market purchase. They were awarded under Sight Sciences’ Non-Employee Director Compensation Program at no cash cost per unit, providing a contingent right to receive common stock upon vesting conditions being satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
